Palmoplantar Pustulosis Induced By Adalimumab: A Case Report

نویسندگان

  • Abdullah Erman Yagiz
  • Nilgul Ustun
  • Ebru Celik
  • Halil Ogut
  • Musa Demirkapi
  • Mustafa Sahan
  • Hayal Guler
  • Ayse Dicle Turhanoglu
چکیده

TNF-α antagonists are used to treat a wide spectrum of moderate to severe inflammatory conditions such as ankylosing spondylitis (AS). During these treatments, cutaneous adverse effects may occur like psoriatic skin lesions. In this case report, we presented an unusual case of a 44 year old women with AS receiving adalimumab who developed an exacerbation of palmoplantar pustulosis. In conclusion, it should be kept in mind that psoriatic skin lesion may develop in patients receiving TNF-α antagonists and these findings may regress when the drug is withdrawn.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Amicrobial pustulosis of the folds and palmoplantar pustulosis simultaneously induced by different tumor necrosis factor-α inhibitors: Demonstration of a shared pathophysiology

APF: amicrobial pustulosis of the folds IBD: inflammatory bowel disease IFN-a: interferon-a PPP: palmoplantar pustulosis TNF-a: tumor necrosis factor-a INTRODUCTION Amicrobial pustulosis of the folds (APF) and palmoplantar pustulosis (PPP) are 2 rare autoinflammatory neutrophilic dermatoses. Many studies report PPP triggered by treatment of inflammatory bowel disease (IBD) with tumor necrosis f...

متن کامل

Combination biologic therapy for the treatment of severe palmoplantar pustulosis

IL: interleukin INTRODUCTION Psoriasis is a common chronic disease andmay be the most prevalent autoimmune disease. The estimated prevalence is 2% to 4% of the global population. Fortunately, providers have a plethora of medications to choose from, but even so, some cases can be very difficult to treat. Herein, we present a challenging case of palmoplantar pustulosis primarily affecting the sol...

متن کامل

The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review

INTRODUCTION Palmoplantar psoriasis (PP) and palmoplantar pustulosis (PPP) are diseases affecting the hands and/or feet that can cause marked physical discomfort and functional disability. The tumor necrosis factor-alpha antagonists adalimumab, etanercept, and infliximab, the interleukin (IL)-17A inhibitors ixekizumab and secukinumab, and the IL-23 or IL-12/IL-23 inhibitors guselkumab and ustek...

متن کامل

Pustular Palmoplantar Psoriasis Successfully Treated with Nb-UVB Monochromatic Excimer Light: A Case-Report

Barber's palmoplantar pustulosis (PPP) is a form of localised pustular psoriasis, affecting the palmar and plantar surfaces. It is a chronic disease, with a deep impact on the patients' quality of life. The Authors discuss a case of Baber Psoriasis successfully treated with monochromatic excimer light.

متن کامل

Palmoplantar pustulosis and smoking.

A multicentre case-control study of 216 patients with palmoplantar pustulosis and 626 controls with miscellaneous dermatoses showed a considerably higher prevalence of smoking in the group with palmoplantar pustulosis. This was the first indication that smoking may be an important factor in this skin disease, possibly by affecting the inflammatory responses of the skin.

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2014